Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Genome, Bacterial
MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer.
Panniculitis, Peritoneal
Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura.
Ribose
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
Return to Top
Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura.
Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura. Int J Hematol. 2005 Feb; 81(2):119-25.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Chronic Disease
Drug Therapy, Combination
Hemorrhage
Humans
Immunosuppressive Agents
Prognosis
Purpura, Thrombocytopenic, Idiopathic
Rituximab
Splenectomy
authors with profiles
James N George